Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: Phase 1 results from a multicentre, open-label, phase 1/2 study

April 2, 2018

Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: Phase 1 results from a multicentre, open-label, phase 1/2 study

Published on 04/01/2018

previous post: Association of placebo, indomethacin, ibuprofen, and acetaminophen with closure of hemodynamically significant patent ductus arteriosus in preterm infants: A systematic review and meta-analysis
next post: Intratumoral and peritumoral lymphovascular invasion detected by D2–40 immunohistochemistry correlates with metastasis in primary cutaneous Merkel cell carcinoma